
News|Articles|December 28, 2023
Antimicrobials: The Year in Review
Author(s)Contagion Editorial Team
This year saw the approval of new therapies as well as the continued evolution of time-to-treat infections and updated guidelines.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contagion Live
1
Once-Weekly HIV Pill Meets Phase 3 Endpoints, Advancing Potential First Long-Acting Oral Treatment
2
What the FDA Approval of Bulevirtide (Hepcludex) Means for Chronic Hepatitis D Treatment
3
Wastewater Surveillance’s Role in Identifying Measles Outbreaks
4
ATB Finder Aims to Transform Antibiotic Selection by Replicating Real-World Infection Conditions
5






































































































































































